MAM. A. Anisimov

M. A. Anisimov

*This is an algorithmically generated author record based on publicly available information.

M. A. Anisimov has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Maintaining conductance of upper respiratory airways in a patient with thyroblastoma. Clinical case

    by Tatiana E. Selina, V. E. Gruzdev, A. A. Afanasenkov, M. A. Anisimov, A. M. Mudunov, V. V. Vereshchak, I. N. Yurichev

    Thyroblastoma is a fast-growing thyroid tumor resistant to the majority of modern chemotherapy regimens. Invasiveness and growth rate cause fast development of changes in the anatomy of the upper airways threatening patient’s life. In this description of a clinical case, we present an example of how we safely maintained conductance of the upper respiratory airways during surgery to treat this disease.

  • Open Access

    New peptide analgesic, μ1-opioid receptor agonist tafalgin, in multimodal pain management. First results of using in a multidisciplinary hospital

    by V. E. Gruzdev, M. A. Anisimov, Yu. E. Ryabukhina, A. V. Oskolkov, P. A. Zeynalova, Ю. Е. Рябухина

    Therapy of chronic pain syndrome and adequate perioperative pain management during treatment of malignant neoplasms are important problems at the current stage of clinical medicine development. Currently, multimodal pain management is effectively applied through drugs of various pharmacological groups prescribed depending on pain intensity in accordance with a digital rating scale. Associated adverse events as well as impossibility of using peroral or transdermal forms in some cases, limit the use of opioid analgesics. High bioavailability and fast absorption of μ1-opioid receptor agonist tafalgin shown during preclinical studies, relatively favorable safety profile allowed to use this drug in oncological clinic.An experience of using tafalgin in treatment of pain syndrome in patients with malignant tumors at the “Lapino” clinical hospital since 2022 is presented. The effectiveness of the drug is evaluated, and its niche in multimodal pain management is determined.


  • Open Access

    Optimization of the method of continuous anesthesia in cardiac surgery patients: two clinical observations

    by M. A. Dzhopua, V. E. Gruzdev, M. A. Anisimov, V. E. Gordobaev, A. V. Tatarenko

    This paper describes the first experience of the department in using an electronic infusion pump in order to optimize and select an adequate and safe method of permanent analgesia in cardiac surgery patients in the perioperative period. Two clinical cases of using an infusion pump for continuous anesthesia are also presented.

  • Open Access

    First experience of trachea stenting using a Y-shaped stent. Clinical observation

    by I. N. Iurichev, V. V. Vereshchak, V. E. Gruzdev, M. A. Anisimov, A. A. Filatov

    Endoscopic trachea stenting is a pressing issue in modern endoscopy. This method is applied in various diseases including benign stenoses associated with complications after long-term mechanical ventilation, malignant stenoses (oncological diseases of the trachea itself, compression from outside by esophageal or mediastinal tumors), post-injury stenoses and developmental defects.Currently, a certain contingent of patients exists for whom trachea prosthesis and its bifurcation remain the only possible option for stepwise or final treatment. If the lower third of the trachea, bifurcation zone or the main bronchi are affected, the optimal technique is stenting with Y-shaped stents which provide maximal patency of the airways.

  • Open Access

    Perioperative pain management in opioid-dependent patient with chronic pain: Current approaches and hidden dangers. Clinical case

    by V. E. Gruzdev, M. A. Anisimov, E. V. Glukhov

    Severe chronic pain syndrome with high requirement for opioids is frequently complicated by opioid tolerance, hyperalgesia, and other side effects. Special complications occur during anesthesia for high-injury surgical interventions and in the postoperative period. Perioperative pain management in these patients requires planning, multimodal approach, combination methods, and prevention of complications including specific complications. This article describes a case of successful surgical treatment of pancreatic cancer in a patient with severe chronic pain syndrome, opioid tolerance, and hyperalgesia. Perioperative period was complicated by high requirement for epidural pain management and use of adjuvants, acute strangulating intestinal obstruction on day 6 of the postoperative period. The authors had to differentiate between pain syndrome and abstinence multiple times and encountered the problem of tachyphylaxis to local anesthetics. Due to thought-out and flexible system of combination multimodal pain management, pain syndrome was relieved, and the patient was discharged in satisfactory condition without the need for opioids.

  • Open Access

    Clinical observation of a 64-year-old female patient with plasma cell leukemia diagnosed during coronavirus infection COVID-19

    by Yu. E. Ryabukhina, O. L. Timofeeva, P. A. Zeynalova, F. M. Abbasbeyli, M. V. Antonets, V. E. Gruzdev, M. A. Anisimov, A. A. Akhobekov, N. A. Kupryshina, Ю. Е. Рябухина

    Plasma cell leukemia (PCL) is a rare malignant plasma cell neoplasm with aggressive clinical progression, minimal response to therapy and unfavorable prognosis. Concomitant new coronavirus infection COVID-19 and its complications significantly worsen prognosis in patients with PCL. Currently, approaches to PCL therapy are not finalized, and regimens developed for multiple myeloma are used. In PCL, the most common clinical symptoms are renal failure and hypercalcinemia which are frequently observed in multiple myeloma. Therefore, use of proteasome inhibitor (bortezomib) with proven effectiveness in multiple myeloma, is justified. A clinical observation of a 64-year-old female patient who was hospitalized in poor physical condition with the new coronavirus infection COVID-19 is presented. During hospitalization, debut of PCL was suspected, and as soon as possible after diagnosis confirmation using vital indications, antitumor drug therapy was started with positive effect.

  • Open Access

    Safe drug therapy in clinical practice: experience of using microinfusion single-use mechanical systems in treatment of patients with malignant diseases of hematopoietic tissue and solid tumors

    by Yu. E. Ryabukhina, P. A. Zeynalova, V. E. Gruzdev, M. A. Anisimov, A. A. Fedenko, O. L. Timofeeva, F. M. Abbasbeyli, D. A. Chekin, A. G. Zhukov, Ю. Е. Рябухина

    Recently due to significant successes in drug therapy of malignant tumors, the question of quality of life of patients has become more important. Cyclical drug treatment implies intravenous infusion of antitumor agents. Complications associated with this type of therapy include phlebitis and extravasation and, in some cases, lead to full obliteration of vessel lumen and vast skin and hypoderm necrosis. Multiple venous punctions can with time lead to significant technical difficulties in accessing the vein and limit the continuation of therapy. This drives the necessity to search for rational approaches to patient safety during both outpatient and inpatient antitumor drug treatment. To solve this problem, fully implanted venous port systems were developed and implemented in clinical practice which provide organization of aseptic continuous venous access, as well as infusion pumps (for independent prolonged intravenous therapy). Use of these devices allows for continuity and cycling of treatment process, significantly improves patients' quality of life by not limiting daily activities.In the article we present our experience of using microinfusion single-use mechanical systems for antitumor drug therapy and relief of intense pain syndrome in patients with malignant disorders of hematopoietic tissue and solid tumors.


  • Open Access

    Multimodal continuous approach to pain management in oncological patients (clinic’s first experience)

    by V. E. Gruzdev, M. A. Anisimov

    In current conditions, increased life expectancy led to increased cancer morbidity. Presence of pain syndrome with significant intensity caused development of numerous guidelines on its treatment. Currently, pain management is based on the stepwise multimodal approach of the World Health Organization. In our opinion, wide application of narcotic analgesics is a disadvantage of this method. This pharmaceutical group has a significant number of adverse effects including addiction, development of hyperalgesia, and potential effect of increased rate of cancer recurrence.The study objective is to optimize the stepwise approach by addition of continuous multimodal analgesia. We aim to develop the principles of complex approach to pain management including new combinations of pharmaceuticals of different modalities and new techniques of continuous safe administration using innovative devices.The article presents a prospective description of a series of clinical cases in which new combinations of pharmaceuticals were administered in the context of complex treatment of pain syndrome of significant intensity. Objective evaluation of pain syndrome was performed using the Numeric Rating Scale.Multimodal intravenous pain management using mobile devices administering a mixture of pharmaceuticals in conjunction with basic peroral therapy and widely accepted discrete stepwise approach of the World Health Organization showed first positive results. In our opinion, further studies will allow to 1) decrease the rate of chronic pain syndrome in oncological patients; 2) treat pain syndrome of almost any intensity with preserved quality of life.The first results are encouraging; they show satisfactory effectiveness of the method and its safety. It is necessary to continue studies to develop and standardize the intravenous mixture composition for pain management in the context of the main clinical syndromes determining pain.


  • Open Access

    Perioperative management of patients with concomitant morbid obesity. Guidelines of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists”

    by Igor B. Zabolotskikh, M. A. Anisimov, E. S. Gorobets, A. I. Gritsan, K. M. Lebedinskii, T. S. Musaeva, D. N. Protsenko, N. V. Trembach, R. V. Shadrin, E. M. Shifman, et al.

    According to the latest estimates of the World Health Organization, more than 1 billion people in the world are overweight. In economically developed countries, the proportion of the population with overweight reaches almost 50 %, of which 30 % are obese. In Russia, on average, 30 % of people of working age are obese and 25 % are overweight. Despite the significant economic costs for the prevention and treatment of obesity, mortality at the age of 20–35 with morbid obesity exceeds the average statistical 12 times, mainly from cardiovascular complications. The guidelines provides principles of perioperative management of patients with obesity.


  • Open Access

    RESECTION OF TRACHEAL BIFURCATION IN TREATMENT OF NON-SMALL CELL LUNG CANCER (LITERATURE REVIEW)

    by I. A. Dadyev, М. M. Davydov, A. K. Chekini, M. A. Anisimov, S. S. Gerasimov, M. S. Shogenov, P. I. Akhmedov, M. R. Kanzapetov

    Over the past few years, significant advances in surgical and anesthetic techniques as well as appropriate selection of patients have led to an improvement in the immediate and long-term treatment outcomes in patients with non-small cell lung cancer with involvement of tracheal bifurcation. In accordance with the current selection criteria, patients with contralateral lymph node metastases (lung root, aortic window, paratracheal area) require chemotherapy or chemoradiotherapy with subsequent estimation of follow-up and treatment strategy. Surgeries with resection of tracheobronchial bifurcation are considered technically complicated, and they should be performed in carefully selected lung cancer patients and only in specialized centers with extensive experience. It allows the incidence of intra-and postoperative complications to be significantly reduced.